Natasa Obermajer (Nataša Obermajer)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 4

Top Topics

Natural Killer Cells

Regulatory T Cells

Long Non Coding Rna

Top Venues

Cancer immunology research

Nature protocols

Research square

This page only lists publications with an associated author ORCID identifier.

Publications

Bowen Dong, Natasa Obermajer, Takemasa Tsuji, Junko Matsuzaki, Cindy M Bonura, Cindy Sander, Henry G Withers, Mark D Long, Colin Chavel, Scott H Olejniczak, Hans Minderman, Joanne M Jeter, Robert P Edwards, Walter J Storkus, Pedro Romero, Pawel Kalinski
NK Receptor Signaling Lowers TCR Activation Threshold, Enhancing Selective Recognition of Cancer Cells by TAA-Specific CTLs. Cancer immunology research (2024)
Bowen Dong, Natasa Obermajer, Takemasa Tsuji, Junko Matsuzaki, Cindy M Bonura, Cindy Sander, Henry G Withers, Mark D Long, Colin Chavel, Scott H Olejniczak, Hans Minderman, Joanne M Jeter, Robert P Edwards, Walter J Storkus, Pedro Romero, Pawel Kalinski
NK Receptor Signaling Lowers TCR Activation Threshold, Enhancing Selective Recognition of Cancer Cells by TAA-Specific CTLs. Cancer immunology research (2024)
Pawel Kalinski, Bowen Dong, Natasa Obermajer, Takemasa Tsuji, Junko Matsuzaki, Cindy Bonura, Henry Withers, Mark Long, Colin Chavel, Scott H Olejniczak, Hans Minderman, Robert Edwards, Walter Storkus, Pedro Romero
NK Receptors Replace CD28 As the Dominant Source of Signal 2 for Cognate Recognition of Cancer Cells by TAA-specific Effector CD8+ T Cells. Research square (2023)
Natasa Obermajer, Julie Urban, Eva Wieckowski, Ravikumar Muthuswamy, Roshni Ravindranathan, David L Bartlett, Pawel Kalinski
Promoting the accumulation of tumor-specific T cells in tumor tissues by dendritic cell vaccines and chemokine-modulating agents. Nature protocols 13 (2) (2018)